Initial Hodgkin treatment of the frail elderly Journal Article


Author: Straus, D. J.
Article Title: Initial Hodgkin treatment of the frail elderly
Abstract: In this issue of Blood, Friedberg and colleagues present results of a clinical trial that suggests a new treatment option for frail Hodgkin lymphoma (HL) patients, age 60 years and older. © 2017 by The American Society of Hematology.
Keywords: adult; treatment outcome; treatment response; aged; review; drug safety; dacarbazine; sensory neuropathy; peripheral neuropathy; bendamustine; drug effect; hodgkin disease; remission; frail elderly; phase 2 clinical trial (topic); brentuximab vedotin; humans; human; priority journal
Journal Title: Blood
Volume: 130
Issue: 26
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-28
Start Page: 2813
End Page: 2814
Language: English
DOI: 10.1182/blood-2017-10-812966
PUBMED: 29284610
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 February 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David J Straus
    356 Straus